Posts tagged Celgene Corporation


Celgene Corporation (CELG) Provides Update on the Fusion Clinical Program

Celgene Corporation (NASDAQ:CELG) announced that the FDA has placed a partial clinical hold on five …

Celgene Corporation (CELG) Announces Phase 2a Results from Oral CC-220 in Patients with Lupus

Celgene Corporation (NASDAQ:CELG) announced results from the phase 2a SLE-001 trial evaluating CC-220, the Company’s …

Celgene Corporation and Acceleron Announce Completion of Target Enrollment in MEDALIST and BELIEVE Phase 3 Studies

Celgene Corporation (NASDAQ:CELG) and Acceleron Pharma (NASDAQ:XLRN) announced that they have completed target enrollment in …

Celgene Corporation (CELG) Shares Slip; Here’s Why

Celgene Corporation (NASDAQ:CELG) shares are down nearly 2% this morning, after the drug giant reported mixed first-quarter …

Stock Update (NASDAQ:CELG): Celgene Corporation Announces Positive Phase III Results in Relapsing Multiple Sclerosis

Celgene Corporation (NASDAQ:CELG) announced that its phase III SUNBEAM trial, evaluating the efficacy and safety …

Friday’s Biotech Insights: Celgene Corporation (CELG), Synergy Pharmaceuticals Inc (SGYP)

Oppenheimer analysts are chiming in with upbeat forecasts on two biotech players: Celgene Corporation (NASDAQ:CELG) …

BTIG Reiterates Buy on Celgene Corporation (CELG) Despite Weak International Revlimid Sales

In a research report released Thursday, BTIG analyst Dane Leone reiterated a Buy rating on …

Cantor Bullish on Celgene Corporation (CELG) After Raising Guidance; Sees 36% Upside

Cantor analyst Mara Goldstein came out today with a bullish note on shares of Celgene Corporation …